Immunocore Holdings plc reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was GBP 47.76 million compared to GBP 32 million a year ago. Net loss was GBP 14.08 million compared to GBP 6.12 million a year ago. Basic loss per share from continuing operations was GBP 0.29 compared to GBP 0.14 a year ago.
For the six months, revenue was GBP 92.31 million compared to GBP 54.48 million a year ago. Net loss was GBP 30.77 million compared to GBP 22.25 million a year ago. Basic loss per share from continuing operations was GBP 0.64 compared to GBP 0.51 a year ago.